The role of interleukin-10 in susceptibility of BALB/c mice to infection with Leishmania mexicana and Leishmania amazonensis

被引:98
作者
Padigel, UM
Alexander, J
Farrell, JP
机构
[1] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA
[2] Univ Strathclyde, Strathclyde Inst Biomed Sci, Glasgow, Lanark, Scotland
关键词
D O I
10.4049/jimmunol.171.7.3705
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Recent studies have demonstrated the critical role of IL-10 in susceptibility to cutaneous and visceral leishmaniasis caused by Leishmania major and Leishmania donovani, respectively. To determine whether IL-10 also plays a similar role in the susceptibility and pathogenesis of cutaneous leishmaniasis caused by the New World species, L. mexicana and L. amazonensis, we analyzed their course of infection in IL-10-deficient BALB/c mice and their wild-type counterparts. Although IL-10-deficient mice infected with either L. mexicana or L. amazonensis failed to control the lesion progression, we did observe consistently lower levels of infection in IL-10(-/-) mice compared with wild-type BALB/c mice. We also observed increased IFN-gamma and NO production and higher levels for IL-12p40 and IL-12Rbeta(2) mRNA in cells from IL-10(-/-) mice compared with cells from BALB/c mice. The mRNA levels for IL-4, which increased significantly in both IL-10(-/-) and BALB/c mice, were comparable. When treated with anti-IL-4 mAb, IL-10(-/-) mice resolved the infection more effectively and had significantly fewer parasites in their lesions compared with similarly treated BALB/c mice. These findings suggest that IL-10, although not the dominant mediator of susceptibility of BALB/c mice to infection with L. mexicana and L. amazonensis, does play a significant role in regulating the development of a protective Th1-type response. However, effective resolution of infection with these New World parasites requires neutralization of both IL-4 and IL-10.
引用
收藏
页码:3705 / 3710
页数:6
相关论文
共 42 条
[1]   IMMUNE-RESPONSES ASSOCIATED WITH SUSCEPTIBILITY OF C57BL/10 MICE TO LEISHMANIA-AMAZONENSIS [J].
AFONSO, LCC ;
SCOTT, P .
INFECTION AND IMMUNITY, 1993, 61 (07) :2952-2959
[2]  
Alexander J, 1999, J CELL SCI, V112, P2993
[3]  
Alexander J, 2002, EUR J IMMUNOL, V32, P2923, DOI 10.1002/1521-4141(2002010)32:10&lt
[4]  
2923::AID-IMMU2923&gt
[5]  
3.0.CO
[6]  
2-E
[7]   Biological behavior of Leishmania amazonensis isolated from humans with cutaneous, mucosal, or visceral leishmaniasis in BALB/c mice [J].
Almeida, RP ;
BarralNetto, M ;
DeJesus, AMR ;
DeFreitas, LAR ;
Carvalho, EM ;
Barral, A .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1996, 54 (02) :178-184
[8]   TRANSFORMING GROWTH-FACTOR-BETA IN LEISHMANIAL INFECTION - A PARASITE ESCAPE MECHANISM [J].
BARRALNETTO, M ;
BARRAL, A ;
BROWNELL, CE ;
SKEIKY, YAW ;
ELLINGSWORTH, LR ;
TWARDZIK, DR ;
REED, SG .
SCIENCE, 1992, 257 (5069) :545-548
[9]   The role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure [J].
Belkaid, Y ;
Hoffmann, KF ;
Mendez, S ;
Kamhawi, S ;
Udey, MC ;
Wynn, TA ;
Sacks, DL .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 194 (10) :1497-1506
[10]  
Buxbaum LU, 2002, EUR J IMMUNOL, V32, P3206, DOI 10.1002/1521-4141(200211)32:11&lt